Sign In
Buy SLNO
$53.01
+0 (+0%)
At Close: Jun 23, 2026
Are SLNO, FORA, AFBI, MKC Obtaining Fair Deals for their Shareholders?
05:30pm, Monday, 06'th Apr 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement
05:20pm, Monday, 06'th Apr 2026
Neurocrine's rare-disease push, anchored by Soleno's VYKAT XR, reshapes biotech dealmaking focus, today, April 6, 2026.
Why Soleno Therapeutics Stock Rocketed Higher on Monday
04:20pm, Monday, 06'th Apr 2026
The deal isn't cheap; the biotech is changing hands at a 34% premium. It gives the buyer a unique product that was FDA-approved barley over a year ago.
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the period March 26, 2025 through November 4, 2025 may wish to
Neurocrine Agrees $2.9 Billion Soleno Deal At 34% Premium
02:28pm, Monday, 06'th Apr 2026
Neurocrine Biosciences (NBIX) is moving to acquire Soleno Therapeutics (SLNO) for $2.9 billion in a deal that could expand its presence in rare genetic disorder
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO)
02:00pm, Monday, 06'th Apr 2026
NEW YORK, April 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is
Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit: Investors Face May 5, 2026, Deadline
12:10pm, Monday, 06'th Apr 2026
Did you buy SLNO common stock between March 26, 2025, and November 4, 2025? Affected Soleno Therapeutics, Inc. Investor Summary Who: Soleno Therapeutics, Inc. (NASDAQ: SLNO) What: Securities fraud c
Bronstein, Gewirtz & Grossman LLC Urges Soleno Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
12:00pm, Monday, 06'th Apr 2026
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Soleno T
New York, New York--(Newsfile Corp. - April 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between M
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
11:40am, Monday, 06'th Apr 2026
LOS ANGELES, April 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. (“S
MILWAUKEE, April 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Soleno (NASDAQ: SLNO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with
Neurocrine Biosciences to acquire Soleno Therapeutics in $2.9B deal
09:57am, Monday, 06'th Apr 2026
Neurocrine Biosciences (NASDAQ:NBIX) has agreed to acquire Soleno Therapeutics (NASDAQ:SLNO) in an all-cash transaction valued at approximately $2.9 billion, it was announced on Monday. Under the term
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to Neurocrine Biosciences for $53.00 per share in cash.
Soleno Therapeutics (SLNO) Faces Securities Class Action Amid Hyperphagia Drug Launch Disruptions -- Hagens Berman
08:40am, Monday, 06'th Apr 2026
SAN FRANCISCO, April 06, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno
SLNO Jumps As Deal Buzz Lifts Stocks
07:58am, Monday, 06'th Apr 2026
Soleno Therapeutics (SLNO) is stealing the spotlight early Monday, jumping 26% premarket as deal talks drive the biggest moves.The surge follows reports that Ne
